Alk-Abello: Opjustering bør ikke give en allergisk reaktion hos investorerne https://www.proinvestor.com/boards/120265

]]>https://dev.proinvestor.com/forum/topic/400886/pharma-maj-2024RSS for NodeSun, 07 Jun 2026 04:31:49 GMTFri, 03 May 2024 02:48:51 GMT60AbbVie: Risankizumab Recommended For EU Approval For Moderately-Severely Active Ulcerative Colitis https://proinvestor.com/investornyt/1166910/abbvie-risankizumab-recommended-for-eu-approval-for-moderately-severely-active-ulcerative-colitis

]]>https://dev.proinvestor.com/forum/post/8038083https://dev.proinvestor.com/forum/post/8038083Fri, 31 May 2024 05:35:15 GMTRegeneron : FDA Extends Review Period For Dupixent As COPD Treatment By Three Month https://proinvestor.com/investornyt/1166896/regeneron-fda-extends-review-period-for-dupixent-as-copd-treatment-by-three-month

]]>https://dev.proinvestor.com/forum/post/8038081https://dev.proinvestor.com/forum/post/8038081Fri, 31 May 2024 04:38:40 GMTSanofi, Regeneron: Dupixent Recommended For EU Approval By CHMP To Treat COPD Patients https://proinvestor.com/investornyt/1166894/sanofi-regeneron-dupixent-recommended-for-eu-approval-by-chmp-to-treat-copd-patients

]]>https://dev.proinvestor.com/forum/post/8038077https://dev.proinvestor.com/forum/post/8038077Fri, 31 May 2024 04:37:50 GMTGod morgen

]]>https://dev.proinvestor.com/forum/post/8038082https://dev.proinvestor.com/forum/post/8038082Fri, 31 May 2024 03:38:17 GMTGilead : Phase 3 Study Of Trodelvy In Metastatic Urothelial Cancer Fails To Meet Primary Endpoint https://proinvestor.com/investornyt/1166858/gilead-phase-3-study-of-trodelvy-in-metastatic-urothelial-cancer-fails-to-meet-primary-endpoint

]]>https://dev.proinvestor.com/forum/post/8038080https://dev.proinvestor.com/forum/post/8038080Fri, 31 May 2024 02:04:07 GMTFDA Acknowledges Astellas Pharma's Resubmission Of BLA For Zolbetuximab https://proinvestor.com/investornyt/1166867/fda-acknowledges-astellas-pharmas-resubmission-of-bla-for-zolbetuximab

]]>https://dev.proinvestor.com/forum/post/8038079https://dev.proinvestor.com/forum/post/8038079Fri, 31 May 2024 02:02:41 GMTiogen : EU Approves Qalsody To Treat Rare, Genetic Form Of Amyotrophic Lateral Sclerosis https://proinvestor.com/investornyt/1166862/biogen-eu-approves-qalsody-to-treat-rare-genetic-form-of-amyotrophic-lateral-sclerosis

]]>https://dev.proinvestor.com/forum/post/8038078https://dev.proinvestor.com/forum/post/8038078Fri, 31 May 2024 02:02:17 GMTNovartis: Phase III Data On Oral Remibrutinib Shows Long-Term Efficacy & Safety In Chronic Urticaria https://proinvestor.com/investornyt/1166865/novartis-phase-iii-data-on-oral-remibrutinib-shows-long-term-efficacy-amp-safety-in-chronic-urticaria

]]>https://dev.proinvestor.com/forum/post/8038073https://dev.proinvestor.com/forum/post/8038073Fri, 31 May 2024 02:01:47 GMTALK har søgt om godkendelse af tablet mod træpollenallergi i børn og unge https://proinvestor.com/investornyt/1166430/alk-har-sogt-om-godkendelse-af-tablet-mod-traepollenallergi-i-born-og-unge

]]>https://dev.proinvestor.com/forum/post/8038071https://dev.proinvestor.com/forum/post/8038071Thu, 30 May 2024 10:51:25 GMTAstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates https://www.proinvestor.com/investornyt/1161783/astrazeneca-to-build-15-bln-manufacturing-facility-in-singapore-for-antibody-drug-conjugates

]]>https://dev.proinvestor.com/forum/post/8038069https://dev.proinvestor.com/forum/post/8038069Mon, 20 May 2024 04:44:42 GMTLundbeck flyvende fra start i 2024 trods bump på vejen for nøgleprodukt https://www.proinvestor.com/investornyt/1159953/lundbeck-flyvende-fra-start-i-2024-trods-bump-pa-vejen-for-nogleprodukt

]]>https://dev.proinvestor.com/forum/post/8038075https://dev.proinvestor.com/forum/post/8038075Wed, 15 May 2024 04:47:21 GMTALK får sat kursmålet op med en femtedel af Jefferies https://www.proinvestor.com/chathistory/-167/gubra

]]>https://dev.proinvestor.com/forum/post/8038074https://dev.proinvestor.com/forum/post/8038074Tue, 07 May 2024 03:05:06 GMTALK får lagt 25 pct. oven i kursmålet hos Danske Bank https://www.proinvestor.com/investornyt/1155325/alk-far-lagt-25-pct-oven-i-kursmalet-hos-danske-bank

]]>https://dev.proinvestor.com/forum/post/8038072https://dev.proinvestor.com/forum/post/8038072Mon, 06 May 2024 07:03:12 GMTALK's topchef om optimeringsplan: Skal sikre råderum til investeringer og bedre bundlinje https://www.proinvestor.com/investornyt/1154419/alks-topchef-om-optimeringsplan-skal-sikre-raderum-til-investeringer-og-bedre-bundlinje

]]>https://dev.proinvestor.com/forum/post/8038070https://dev.proinvestor.com/forum/post/8038070Fri, 03 May 2024 07:47:00 GMTALK's topchef om regnskab: Vi er superglade for fantastisk fint kvartal i
Europa https://www.proinvestor.com/investornyt/1154406/alks-topchef-om-regnskab-vi-er-superglade-for-fantastisk-fint-kvartal-i-europa

]]>https://dev.proinvestor.com/forum/post/8038076https://dev.proinvestor.com/forum/post/8038076Fri, 03 May 2024 05:55:20 GMT